The pathogenesis of multiple system atrophy: Past, present, and future

Movement Disorders

Volumn 15, Issue 5, 2000, Pages 784-788

  Mizuta, Ikuko ^a   Mizuta, Eiji ^a,b   Yamasaki, Shunzou ^a,b   Kuno, Sadako ^a,b   Yasuda, Minoru ^c   Tanaka, Chikako ^c  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b Japan Foundation for Aging and Health   (Japan)

^c Hyogo Institute for Aging Brain and Cognitive Disorders   (Japan)

Author keywords

Synuclein; Glial cytoplasmic inclusion; Multiple system atrophy; Pathogenesis

Indexed keywords

ALPHA SYNUCLEIN; NEU DIFFERENTIATION FACTOR; TAU PROTEIN;

CELL INCLUSION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; GLIA CELL; HUMAN; LEWY BODY; OLIGODENDROGLIA; ONSET AGE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SHY DRAGER SYNDROME;

BIOLOGICAL MARKERS; BRAIN; GENE EXPRESSION REGULATION; GENES, REGULATOR; HUMAN; INCLUSION BODIES; MULTIPLE SYSTEM ATROPHY; MUTATION; NERVE TISSUE PROTEINS; NEUREGULINS; OLIGODENDROGLIA; POLYMORPHISM (GENETICS); TAU PROTEINS;

EID: 0033819138     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200009)15:5<784::AID-MDS1004>3.0.CO;2-P     Document Type: Review

References (61)

1. Consensus statement on the diagnosis of multiple system atrophy
2. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)
3. Argyrophilic ubiquinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy)
4. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy
5. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology
6. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: A correlation between the density of GCIs and the degree of involvement of the striatonigral and olivopontocerebellar system
7. Cell death mechanisms in multiple system atrophy
8. Disorders of movement and system degenerations
9. Multiple system atrophy: A review of 203 pathologically proven cases
10. Cellular pathology of multiple system atrophy: A review
11. P53- and CD95-associated apoptosis in neurodegenerative diseases
12. 11C]PK11195-PET indicates involvement of the globus pallidum in idiopathic Parkinson's disease
13. Caspases as treatment targets in stroke and neurodegenerative diseases
14. Involvement of caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons
15. Is caspase-3 a vulnerability factor and final effector in apoptotic death of dopaminergic neurones in Parkinson's disease?
16. Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: Immunohistochemical and ultrastructural studies
17. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease
18. Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
19. Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy
20. Review: Tau protein pathology in Alzheimer's disease and related disorders
21. Increased tau immunoreactivity in oligodendrocytes following human stroke and head injury
22. Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: Involvement of free radicals
23. Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes
24. Ubiquitinated αβ-crystallin in glial cytoplasmic inclusions from the brain of a patient with multiple system atrophy
25. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
26. Multiple system atrophy: A new alpha-synuclein disease?
27. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
28. Accumulation of α-synuclein/NACP is a pathological feature common to Lewy body disease and multiple system atrophy
29. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
30. Identification of two distinct synucleins from human brain
31. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
32. Multiple system atrophy: Sporadic or familial?
33. Environmental-occupational risk factors and family associations in multiple system atrophy: A preliminary investigation
34. A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy
35. Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy
36. Apoprotein E e4 allele frequency in patients with multiple system atrophy
37. Multiple system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration
38. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation
39. Mutation in the α-synuclein gene identified in families with Parkinson's disease
40. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
41. Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's disease
42. The role of the alpha-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom
43. No mutation in the entire coding region of the α-synuclein gene in pathologically confirmed cases of multiple system atrophy
44. Mutation screening in the α-synuclein gene in MSA
45. Genetic studies in Alzheimer's disease with an NACP/α-synuclein polymorphism
46. Mutation screening in exons 3 and 4 of α-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases
47. Increased susceptibility to sporadic Parkinson's disease by a certain combined α-synuclein/apolipoprotein E genotype
48. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
49. α-Synuclein shares physical and functional homology with 14-3-3 proteins
50. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
51. Cloning and mapping of ZNF231, a novel brain-specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA)
52. Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis
53. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors
54. GGF/neuregulin induces a phenotypic reversion of oligodendrocytes
55. A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development
56. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3
57. Effect of neu differentiation factor isoforms on neonatal oligodendrocyte function
58. Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation
59. Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina
60. A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis
61. Neuregulin-β induces expression of an NMDA-receptor subunit